EODData

FRA, 5GH: GUARDANT HEALTH CL. A

02 Oct 2025
LAST:

53.20

CHANGE:
 0.42
OPEN:
53.20
HIGH:
53.20
ASK:
0.00
VOLUME:
250
CHG(%):
0.78
PREV:
53.62
LOW:
53.20
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
02 Oct 2553.2053.2053.2053.20250
01 Oct 2552.8653.6252.8653.620
30 Sep 2552.5652.5652.5652.560
29 Sep 2551.0251.8451.0251.8470
26 Sep 2551.4851.8651.4851.86100
25 Sep 2548.9148.9148.9148.91341
24 Sep 2550.3250.3250.3250.32341
23 Sep 2550.4250.4250.4250.42341
22 Sep 2550.1250.1250.1250.12341
19 Sep 2549.8449.8449.8449.84341

COMPANY PROFILE

Name:GUARDANT HEALTH CL. A
About:Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company provides precision oncology testing services comprising Guardant360, a panel of genetic tests; Guardant360 LDT that measures 730+ genes and supports all guideline-recommended biomarkers; Guardant360 CDx Test, a liquid biopsy test; Guardant360 Response Test, a blood-only liquid biopsy; Guardant360 TissueNext Test, a tissue-based test with AI-powered PD-L1 detection; GuardantINFINITY Test that provides insights into the complexities of tumor molecular profiles and immune response to advance cancer research and therapy development; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI blood test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It also offers Shield Test; Guardant Reveal Test for adjuvant treatment and surveillance settings in early-stage cancer patients; and Smart Liquid Biopsy Platform. In addition, the company provides development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kit fulfillment and delivery of Shield screening tests. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
Sector:Healthcare
Address:3100 Hanover Street, Palo Alto, CA, United States, 94304
Website:https://guardanthealth.com
ISIN:US40131M1099
LEI:254900M8C3E5VC8BR186

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

TECHNICAL INDICATORS

MA5:52.62
MA10:51.27
MA20:50.10
MA50:48.50
MA100:44.35
MA200:41.86
STO9:91.08
STO14:94.13
RSI14:70.19
WPR14:-5.87
MTM14:6.59
ROC14:0.14
ATR:0.94
Week High:53.62
Week Low:48.91
Month High:57.68
Month Low:46.46
Year High:57.68
Year Low:18.52
Volatility:43.65